Data driven discovery and AI are reshaping how new medicines progress from concept to clinic. Biotechx Europe 2026 gathers stakeholders working at the intersection of drug discovery, data science and clinical development.
Practical information for Biotechx Europe 2026
Dates and venue. Biotechx Europe 2026 runs from 6 to 8 October 2026 at Messe Basel, Switzerland. Ticketing includes paid options from €2,595 and applications for free passes.
Format. The event mixes an exhibition with a conference and thematic hubs that link discovery, data and healthcare delivery.
Key numbers for the event
- 3 days of activity
- 150+ exhibitors
- 100+ biotech start-ups
- 3000+ attendees
- 400+ speakers
These figures underline a programme where solution providers for discovery and clinical teams converge with R&D decision makers.
Sectors and exhibitor profile at Basel
Exhibitors cover drug discovery platforms, data management and AI-driven analytics, structural biology tools and clinical research technologies. Start-ups occupy an explicit zone aimed at visibility to investors and pharma R&D teams.
Speakers include senior leads in data science and clinical development, bringing practical perspectives on deploying analytics in regulated environments.
Programme highlights and hubs
Content is organised across dedicated hubs such as Healthcare 4.0, Discovery Disrupted and Data Unleashed. The event combines plenary sessions, thematic tracks, start-up showcases and wellness activities.
Notable speakers listed for 2026 include Manuela Maronati of UCB and Dave Drodge of Roche, among other industry data and R&D leaders.
Commercial prospecting and networking advice
Use the built-in 1-2-1 networking to schedule focused meetings. Tactical recommendations:
- Target heads of data and discovery early; they are primary stakeholders for analytics purchases.
- Craft a 5-minute use case that demonstrates measurable impact on time to result or reproducibility.
- Prepare short, deployable demos and technical integration notes for IT contacts.
- Organise follow-up by priority with a 48-hour cadence for high-potential leads.
Closing note and official link
For companies combining data and discovery capabilities, Biotechx Europe 2026 offers concentrated access to R&D and data decision makers. Check tickets and the full programme at http://www.terrapinn.com/conference/biotechx
